PRECISE-DAPT score

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Synonyms and keywords: PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy;

Overview[edit | edit source]

PRECISE-DAPT score is a validated risk assessment tool designed to predict the risk of bleeding associated with dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor among patients who are treated with coronary stenting.

PRECISE-DAPT score[edit | edit source]

PRECISE-DAPT score is a validated risk assessment tool designed to predict the risk of bleeding associated with dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor among patients who are treated with coronary stenting.^[1]

[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)

[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.

[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] Calculator[edit | edit source]

Shown below is the calculator for [Name of the Score] (check all the boxes that apply):

(insert widget here) {{#widget:Widget_Name}}

Interpretation[edit | edit source]

Score < 25:
Score ≥ 25: Higher risk of thrombotic-ischemic events and a significantly higher risk of death (particularly bleeding related), MI and major bleeding

References[edit | edit source]

↑ Costa, Francesco; van Klaveren, David; James, Stefan; Heg, Dik; Räber, Lorenz; Feres, Fausto; Pilgrim, Thomas; Hong, Myeong-Ki; Kim, Hyo-Soo; Colombo, Antonio; Steg, Philippe Gabriel; Zanchin, Thomas; Palmerini, Tullio; Wallentin, Lars; Bhatt, Deepak L; Stone, Gregg W; Windecker, Stephan; Steyerberg, Ewout W; Valgimigli, Marco (2017). "Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials". The Lancet. 389 (10073): 1025–1034. doi:10.1016/S0140-6736(17)30397-5. ISSN 0140-6736.

[Costavan_Klaveren2017-1] Costa, Francesco; van Klaveren, David; James, Stefan; Heg, Dik; Räber, Lorenz; Feres, Fausto; Pilgrim, Thomas; Hong, Myeong-Ki; Kim, Hyo-Soo; Colombo, Antonio; Steg, Philippe Gabriel; Zanchin, Thomas; Palmerini, Tullio; Wallentin, Lars; Bhatt, Deepak L; Stone, Gregg W; Windecker, Stephan; Steyerberg, Ewout W; Valgimigli, Marco (2017). "Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials". The Lancet. 389 (10073): 1025–1034. doi:10.1016/S0140-6736(17)30397-5. ISSN 0140-6736.